{"id":"https://openalex.org/W4387900920","doi":"https://doi.org/10.1021/acs.jmedchem.3c01398","title":"Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders","display_name":"Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders","publication_year":2023,"publication_date":"2023-10-24","ids":{"openalex":"https://openalex.org/W4387900920","doi":"https://doi.org/10.1021/acs.jmedchem.3c01398","pmid":"https://pubmed.ncbi.nlm.nih.gov/37874905"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.3c01398","doi":"https://doi.org/10.1021/acs.jmedchem.3c01398","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.3c01398","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103001025","display_name":"David Harrison","orcid":"https://orcid.org/0000-0001-6258-3254","observed_orcids":["https://orcid.org/0000-0001-6258-3254"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David Harrison","raw_affiliation_strings":["NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K"],"raw_orcid":"https://orcid.org/0000-0001-6258-3254","affiliations":[{"raw_affiliation_string":"NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026721816","display_name":"Andy Billinton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andy Billinton","raw_affiliation_strings":["NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073915074","display_name":"Mark G. Bock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark G. Bock","raw_affiliation_strings":["NodThera Inc., P.O. Box 156, Suite 1702, 265 Franklin Street, Boston, Massachusetts 02110, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NodThera Inc., P.O. Box 156, Suite 1702, 265 Franklin Street, Boston, Massachusetts 02110, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001836608","display_name":"John R. Doedens","orcid":"https://orcid.org/0000-0001-9551-0019","observed_orcids":["https://orcid.org/0000-0001-9551-0019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John R. Doedens","raw_affiliation_strings":["NodThera Inc., 454 N 34th Street, Seattle, Washington 98103, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NodThera Inc., 454 N 34th Street, Seattle, Washington 98103, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064863646","display_name":"Christopher A. Gabel","orcid":"https://orcid.org/0009-0008-0569-9574","observed_orcids":["https://orcid.org/0009-0008-0569-9574"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher A. Gabel","raw_affiliation_strings":["NodThera Inc., 454 N 34th Street, Seattle, Washington 98103, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NodThera Inc., 454 N 34th Street, Seattle, Washington 98103, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111587458","display_name":"M. Katharine Holloway","orcid":"https://orcid.org/0000-0002-0849-2658","observed_orcids":["https://orcid.org/0000-0002-0849-2658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Katharine Holloway","raw_affiliation_strings":["Gfree Bio LLC, 5824 Brittlyns Ct, Austin, Texas 78730, United States"],"raw_orcid":"https://orcid.org/0000-0002-0849-2658","affiliations":[{"raw_affiliation_string":"Gfree Bio LLC, 5824 Brittlyns Ct, Austin, Texas 78730, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022208988","display_name":"Roderick A. Porter","orcid":"https://orcid.org/0000-0001-8252-0429","observed_orcids":["https://orcid.org/0000-0001-8252-0429"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roderick A. Porter","raw_affiliation_strings":["Rod Porter Consultancy, 89 Back Street, Ashwell, Baldock SG7 5PG, Hertfordshire, U.K"],"raw_orcid":"https://orcid.org/0000-0001-8252-0429","affiliations":[{"raw_affiliation_string":"Rod Porter Consultancy, 89 Back Street, Ashwell, Baldock SG7 5PG, Hertfordshire, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032911877","display_name":"Val\u00e9rie Reader","orcid":"https://orcid.org/0000-0003-1969-2425","observed_orcids":["https://orcid.org/0000-0003-1969-2425"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Val\u00e9rie Reader","raw_affiliation_strings":["NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K"],"raw_orcid":"https://orcid.org/0000-0003-1969-2425","affiliations":[{"raw_affiliation_string":"NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jane Scanlon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jane Scanlon","raw_affiliation_strings":["NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050945744","display_name":"Kenneth Schooley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth Schooley","raw_affiliation_strings":["NodThera Inc., 454 N 34th Street, Seattle, Washington 98103, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NodThera Inc., 454 N 34th Street, Seattle, Washington 98103, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111714417","display_name":"Alan P. Watt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan P. Watt","raw_affiliation_strings":["NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NodThera Ltd., Suite 8, The Mansion, Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, Essex, U.K","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103001025"],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":8.2477,"has_fulltext":false,"cited_by_count":93,"citation_normalized_percentile":{"value":0.98920491,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"66","issue":"21","first_page":"14897","last_page":"14911"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11078","display_name":"Inflammasome and immune disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nlrp3-inhibitors","display_name":"NLRP3 inhibitors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/carbamate-esters","display_name":"carbamate esters","score":0.6899999976158142},{"id":"https://openalex.org/keywords/brain-penetration","display_name":"brain penetration","score":0.6899999976158142},{"id":"https://openalex.org/keywords/neuroinflammatory-disorders","display_name":"neuroinflammatory disorders","score":0.8429999947547913},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.972000002861023},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.906000018119812},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C2777209026","wikidata":"https://www.wikidata.org/wiki/Q412405","display_name":"Inflammasome","level":3,"score":0.918254017829895},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6754845380783081},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.6372300982475281},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.602979302406311},{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.5958283543586731},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49058523774147034},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.4782197177410126},{"id":"https://openalex.org/C2779335537","wikidata":"https://www.wikidata.org/wiki/Q7162617","display_name":"Penetrant (biochemical)","level":2,"score":0.4542374014854431},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.43369126319885254},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.25467634201049805},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23377469182014465},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21458691358566284},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18259596824645996},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17434972524642944},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0851532518863678},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05587714910507202},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000071199","descriptor_name":"NLR Family, Pyrin Domain-Containing 3 Protein","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D000090862","descriptor_name":"Neuroinflammatory Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004952","descriptor_name":"Esters","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058847","descriptor_name":"Inflammasomes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.3c01398","doi":"https://doi.org/10.1021/acs.jmedchem.3c01398","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.3c01398","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:37874905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37874905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1966625479","https://openalex.org/W1970242970","https://openalex.org/W2015283405","https://openalex.org/W2119098586","https://openalex.org/W2134007048","https://openalex.org/W2140427118","https://openalex.org/W2140637559","https://openalex.org/W2155538302","https://openalex.org/W2317835477","https://openalex.org/W2508156341","https://openalex.org/W2757148163","https://openalex.org/W2768967928","https://openalex.org/W2979373607","https://openalex.org/W2990312754","https://openalex.org/W3080545619","https://openalex.org/W3087138729","https://openalex.org/W3091396307","https://openalex.org/W3115892358","https://openalex.org/W3134372162","https://openalex.org/W3205295338","https://openalex.org/W4213006056","https://openalex.org/W4214660540","https://openalex.org/W4288431166","https://openalex.org/W4292385500","https://openalex.org/W4294832923","https://openalex.org/W4295706186","https://openalex.org/W4307181064","https://openalex.org/W4318575219","https://openalex.org/W4321331770"],"related_works":["https://openalex.org/W7125683579","https://openalex.org/W3087138729","https://openalex.org/W7151825441","https://openalex.org/W7212389427","https://openalex.org/W2800938734","https://openalex.org/W7165624224","https://openalex.org/W4404195227","https://openalex.org/W4404615813","https://openalex.org/W7201950205","https://openalex.org/W4407364210"],"abstract_inverted_index":{"The":[0],"NLRP3":[1,40,60,75,92,112,141],"inflammasome":[2,41,61,93,113,142],"is":[3],"a":[4,36,63,104,137],"component":[5,37],"of":[6,15,99,106],"the":[7,13,59,80,89,127],"innate":[8],"immune":[9],"system":[10],"involved":[11],"in":[12,54,57,146],"production":[14],"proinflammatory":[16],"cytokines.":[17],"Neurodegenerative":[18],"disorders,":[19],"including":[20],"Alzheimer\u2019s":[21],"disease,":[22,24],"Parkinson\u2019s":[23],"multiple":[25],"sclerosis,":[26,30],"and":[27,139],"amyotrophic":[28],"lateral":[29],"have":[31,35,52,76],"been":[32,77],"shown":[33,134],"to":[34,68,88,116,125,135],"driven":[38],"by":[39],"activation.":[42],"Diseases":[43],"such":[44],"as":[45,62,110],"these":[46],"with":[47,144],"large":[48],"unmet":[49],"medical":[50],"needs":[51],"resulted":[53],"an":[55,118],"interest":[56],"inhibiting":[58],"potential":[64],"pharmacological":[65],"treatment,":[66],"but":[67],"date,":[69],"no":[70],"marketed":[71],"drugs":[72],"specifically":[73],"targeting":[74],"approved.":[78],"Furthermore,":[79],"requirement":[81],"for":[82,91,96],"CNS-penetrant":[83],"molecules":[84],"adds":[85],"additional":[86],"complexity":[87],"search":[90],"inhibitors":[94],"suitable":[95],"clinical":[97],"investigation":[98],"neuroinflammatory":[100],"disorders.":[101],"We":[102],"designed":[103],"series":[105],"ester-substituted":[107],"carbamate":[108],"compounds":[109],"selective":[111,140],"inhibitors,":[114],"leading":[115],"NT-0796,":[117],"isopropyl":[119],"ester":[120],"that":[121],"undergoes":[122],"intracellular":[123],"conversion":[124],"NDT-19795,":[126],"carboxylic":[128],"acid":[129],"active":[130],"species.":[131],"NT-0796":[132],"was":[133],"be":[136],"potent":[138],"inhibitor":[143],"demonstrated":[145],"vivo":[147],"brain":[148],"penetration.":[149]},"counts_by_year":[{"year":2026,"cited_by_count":43},{"year":2025,"cited_by_count":30},{"year":2024,"cited_by_count":20}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-10-25T00:00:00"}